Skip to main content

Table 3 Selection criteria for Active Surveillance in international published series

From: Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom

Publication

Gleason Score

PSA (ng/ml)

Positive cores

% positive biopsy cores

% cancer involvement per core

cT

Dall’ Era [11]

≤6

<10

-

<33

-

≤2a

Bul [10]

≤7

<20

≤3

-

-

-

Soloway [12]

≤6

≤10

≤2

-

<20

≤2

Tosoian [18]

≤6

≤10

≤2

-

<50

1c

Ercole [13]

≤6

<10

≤2

-

<50

≤2a

Klotz [14]

≤6

≤10

-

-

-

≤2b

Ischia [15]

≤6

<10

-

-

-

≤2a

Thomsen [16]

≤6

≤10

≤3

-

<50

≤2a

Selvadurai [17]

≤6

<15

-

≤50

-

≤2

  1. cT clinical tumour category, PSA prostate specific antigen
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us